Completely unexpectedly, the enzyme ceramidase emerges as a new target structure for the therapy of SARS-CoV-2 infections, researchers report. Completely unexpectedly, the enzyme ceramidase emerges as ...
A recent study posted on the bioRxiv* preprint server explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for developing broad-range pan-coronavirus vaccines. Study: The ...
In a recent preprint* research paper uploaded to the Research Square server, researchers investigated the pathophysiology of post-COVID-19 cognitive defects. They used serum biomarkers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback